Dr. Jeffrey R. Jay, M.D. »

Abivax SA F shares owned by Dr. Jeffrey R. Jay, M.D.

Quarter-by-quarter ownership of Abivax SA F (ABVX) shares owned by Dr. Jeffrey R. Jay, M.D. from 13F filings

Historical chart of Dr. Jeffrey R. Jay, M.D. investment in Abivax SA F

Tip: Access up to 7 years of quarterly data

All positions including Abivax SA F held by Dr. Jeffrey R. Jay, M.D. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abivax SA F by Dr. Jeffrey R. Jay, M.D.

Quarter filed Position value Share count Share price at filing
2023-12-31 $17M 1.6M 10.70

More positions owned by Dr. Jeffrey R. Jay, M.D.

Alpine Immune Sciences (ALPN)
Cytokinetics Com New (CYTK)
Urogen Pharma (URGN)
Pliant Therapeutics (PLRX)
Ultragenyx Pharmaceutical (RARE)
Xenon Pharmaceuticals (XENE)
Rapt Therapeutics (RAPT)
Alkermes SHS (ALKS)
Aerovate Therapeutics (AVTE)
Vaxcyte (PCVX)
Evolus (EOLS)
Anaptysbio Inc Common (ANAB)
Immunocore Hldgs Ads (IMCR)
Neurogene (NGNE)
Amicus Therapeutics (FOLD)

View all positions for Dr. Jeffrey R. Jay, M.D.

Top funds holding Abivax SA F

Blackstone Group
Cormorant Asset Management
Commodore Capital
Dr. Jeffrey R. Jay, M.D.
Franklin Resources
Nantahala Capital Management
VR Adviser
Samsara BioCapital
Citadel Advisors
Henderson Group
Point72 Asset Management
Rosalind Advisors
Polar Securities
Millennium Management
Kennedy Capital Management

View all funds holding Abivax SA F